Novel association between blastocystosis and some hemogram parameters in Iraqi people with and without irritable

Masar Hadi Ismail1, Shatha Khudaier Abbas1, Abdul-Lateef Molan2

  • 1Department of Biology, College of Sciences, Mustansiriyah University, Baghdad, Iraq.

Annals of Parasitology
|December 30, 2022
PubMed

Insights

Blastocystis parasites significantly alter key blood cell counts, including lymphocytes, platelets, monocytes, and neutrophils. These changes, along with elevated ratios like neutrophil-to-lymphocyte ratio (NLR), may serve as novel markers for blastocystosis.

Area of Science:

  • Medical Parasitology
  • Hematology
  • Gastroenterology

Background:

  • Blastocystis parasites are implicated as pathogenic protozoa, with potential links to anemia.
  • Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder.
  • Hematological indices may be affected by parasitic infections.

Purpose of the Study:

  • To compare hematological indices in healthy individuals, Blastocystis-positive subjects, Blastocystis-negative IBS patients, and Blastocystis-positive IBS patients.
  • To evaluate the correlation between blastocystosis and specific hemogram parameters.
  • To identify potential novel markers for Blastocystis infection.

Main Methods:

  • Blood samples were collected from four groups: healthy controls, Blastocystis-positive subjects, Blastocystis-negative IBS patients, and Blastocystis-positive IBS patients.
  • Complete blood count (CBC) was measured for all participants.
  • Six hemogram parameters were analyzed: monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), red cell distribution width (RDW), platelet distribution width (PDW), and mean platelet volume (MPV).

Main Results:

  • Blastocystis infection led to significant decreases in lymphocytes and platelets, and significant increases in monocytes and neutrophils compared to healthy controls.
  • NLR, MLR, PLR, RDW, PDW, and MPV were significantly higher in Blastocystis-infected individuals (both IBS and non-IBS) compared to their Blastocystis-negative counterparts.
  • These findings were observed for the first time.

Conclusions:

  • Elevated levels of NLR, MLR, PLR, RDW, PDW, and MPV can potentially serve as novel diagnostic markers for blastocystosis.
  • Blastocystis parasite infection significantly impacts hematological indices in both IBS patients and non-IBS individuals.

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
221
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
348
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
386
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
277
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
518
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
334